Abstract
The maintenance of intestinal homeostasis is a fundamental process critical for organismal integrity. Sitting at the interface of the gut microbiome and mucosal immunity, adaptive and innate lymphoid populations regulate the balance between commensal micro-organisms and pathogens. Checkpoint inhibitors, particularly those targeting the CTLA-4 pathway, disrupt this fine balance and can lead to inflammatory bowel disease and immune checkpoint colitis. Here, we show that CTLA-4 is expressed by innate lymphoid cells and that its expression is regulated by ILC subset-specific cytokine cues in a microbiota-dependent manner. Genetic deletion or antibody blockade of CTLA-4 in multiple in vivo models of colitis demonstrates that this pathway plays a key role in intestinal homeostasis. Lastly, we have found that this observation is conserved in human IBD. We propose that this population of CTLA-4-positive ILC may serve as an important target for the treatment of idiopathic and iatrogenic intestinal inflammation.
Original language | English |
---|---|
Article number | 9520 |
Pages (from-to) | 9520 |
Journal | Nature Communications |
Volume | 15 |
Issue number | 1 |
DOIs | |
Publication status | Published - 4 Nov 2024 |
Keywords
- Animals
- CTLA-4 Antigen/metabolism
- Immunity, Innate
- Homeostasis
- Humans
- Mice
- Intestinal Mucosa/immunology
- Gastrointestinal Microbiome/immunology
- Lymphocytes/immunology
- Colitis/immunology
- Mice, Inbred C57BL
- Female
- Inflammatory Bowel Diseases/immunology
- Mice, Knockout
- Male
- Cytokines/metabolism
- Disease Models, Animal
- Immunity, Mucosal